<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04799093</url>
  </required_header>
  <id_info>
    <org_study_id>CAN-B</org_study_id>
    <nct_id>NCT04799093</nct_id>
  </id_info>
  <brief_title>Eye Movement Tracking to Detect Impairment Due to Acute Cannabis Intoxication</brief_title>
  <official_title>Eye Movement Tracking to Detect Impairment Due to Acute Cannabis Intoxication</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oculogica, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oculogica, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the accuracy of an impairment algorithm based on&#xD;
      eye tracking while watching a short film clip, in comparison to a clinical reference standard&#xD;
      of impairment.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2021</start_date>
  <completion_date type="Actual">September 7, 2021</completion_date>
  <primary_completion_date type="Actual">September 7, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Impairment assessment correlation with EyeBOX assessment</measure>
    <time_frame>Within an hour</time_frame>
    <description>A correlation between impairment as assessed by standard impairment tests and the EyeBOX assessment of impairment as determined by an algorithm.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">225</enrollment>
  <condition>Impairment</condition>
  <condition>Cannabis Intoxication</condition>
  <arm_group>
    <arm_group_label>Cannabis users</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Normals</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>EyeBOX</intervention_name>
    <description>Eye-Tracking based diagnostic</description>
    <arm_group_label>Cannabis users</arm_group_label>
    <arm_group_label>Normals</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy habitual cannabis-smoking subjects, i.e., smoke or consume cannabis at least three&#xD;
        times a week, and healthy occasional cannabis-smoking subjects, i.e., smoke or consume once&#xD;
        a week will be recruited from the local area.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Provide written informed consent.&#xD;
&#xD;
          2. Have the ability to provide a complete ophthalmologic, medical and neurologic history&#xD;
             as well as report medications/drugs/alcohol consumed within the 24 hours prior to&#xD;
             tracking.&#xD;
&#xD;
          3. Be at least 18 years old.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Be blind (no light perception), have missing or non-functional eyes.&#xD;
&#xD;
          2. Be unable to open their eyes.&#xD;
&#xD;
          3. Have a history of unresolved strabismus, diplopia, amblyopia.&#xD;
&#xD;
          4. Have a history of unresolved cranial nerve III, IV, or VI palsy.&#xD;
&#xD;
          5. Have a history of unresolved macular edema, retinal degeneration, extensive cataract,&#xD;
             or ocular globe disruption.&#xD;
&#xD;
          6. Have a history of extensive prior eye surgery (examples include strabismus surgery,&#xD;
             scleral buckle repair of retinal detachment, repair of blow out fractures of the orbit&#xD;
             and any procedures that would interfere with extraocular muscle movements; prior&#xD;
             cataract surgery or Lasik are not exclusions) or scarring.&#xD;
&#xD;
          7. Have a prior history of unresolved ocular-motor dysfunctions.&#xD;
&#xD;
          8. Have used cannabis, alcohol etc. 24 hours before study commences.&#xD;
&#xD;
          9. Be 100% na√Øve to cannabis usage.&#xD;
&#xD;
         10. Be pregnant.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rosina Samadani, Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>Oculogica, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Integrated Medicine LLC</name>
      <address>
        <city>Westport</city>
        <state>Connecticut</state>
        <zip>06880</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 11, 2021</study_first_submitted>
  <study_first_submitted_qc>March 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 16, 2021</study_first_posted>
  <last_update_submitted>September 10, 2021</last_update_submitted>
  <last_update_submitted_qc>September 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Marijuana Abuse</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

